
Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. (INTI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INTI · earnings · updated Jun 9, 2026
Next Earnings Date
About Earnings & Data Methodology
Inhibitor Therapeutics, Inc. (INTI) reports earnings quarterly as a OTC-listed Biotechnology company.
Each quarter, investors track INTI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INTI revenue tab →
Frequently asked questions
INTI earnings · 3 questionsInhibitor Therapeutics, Inc.'s next earnings report is expected around TBD. INTI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INTI historically reports after market close (AMC).
▸ Source: FMP · Inhibitor Therapeutics, Inc. SEC filings · US GAAP · Inhibitor Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026